Buy Pyrazolam 2.5 mg Pellets – Premium Research Chemical | euro-labchems.com

Buy Pyrazolam 2.5 mg Pellets (8-Bromo-1-methyl-6-(pyridin-2-yl)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine) CAS Number: 39243-02-2 Molecular Formula: C₁₆H₁₂BrN₅ Molecular Weight: 354.21 g/mol Purity: ≥98.5% (HPLC verified) Dosage per pellet: Exactly 2.5 mg Pyrazolam Form: Compressed pharmaceutical-grade pellets (uniform, scored for precision) Quantity options: 10, 20, 50, 100, 200 pellets Shipping: Discreet worldwide, vacuum-sealed, moisture-proof packaging

euro-labchems.com supplies laboratory-verified Pyrazolam 2.5 mg pellets – a potent designer triazolobenzodiazepine research chemical first reported in underground markets around 2012–2013. Structurally related to alprazolam and bromazolam, Pyrazolam is one of the most selective anxiolytic benzodiazepines, showing exceptionally high affinity for α2/α3 GABA-A receptor subunits while having reduced activity at α1 (sedation) and α5 (memory impairment) subunits.

What is Pyrazolam?

Pyrazolam (8-bromo-1-methyl-6-(pyridin-2-yl)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine) is a research benzodiazepine prized for its predominant anxiolytic profile with significantly less sedation, amnesia, and motor impairment compared to classical 1,4-benzodiazepines. The 2.5 mg pellet is a standard/common research dose for studying selective GABA-A subtype modulation, anxiolytic mechanisms, and behavioral pharmacology.

Key Product Specifications of Pyrazolam 2.5 mg Pellets

• Pellet size: Small, consistent 3–4 mm diameter
• Excipients: Inert binders for stability & accurate dosing
• Stability: Excellent cool/dark/dry storage (2+ years)
• Potency: 2.5 mg per pellet – standard research dose (analog potency: 1.5–4 mg common)

Research Effects & Characteristics

Duration: 10–18 hours Onset: 45–120 minutes Peak: 3–8 hours

Preclinical and analog literature indicate strong anxiolytic effects with minimal sedation: pronounced reduction of anxiety/fear responses, muscle relaxation at higher doses, mild anticonvulsant activity, and relatively preserved cognitive/motor function. Frequently described as one of the “cleanest” benzodiazepines for anxiety-focused research with low hypnotic and amnesic liability.

Possible side effects (dose-dependent, research observations): mild sedation at higher doses, rebound anxiety, tolerance/dependence potential, ataxia, respiratory depression risk (rare at research doses), rare paradoxical agitation.

Pyrazolam 2.5 mg pellets are sold strictly for scientific research – not for human/veterinary consumption. Verify local regulations. Full CoA available.

Premium Pyrazolam pellets for precise GABA-A subtype research from euro-labchems.com – your trusted specialist.